MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Deep learning‐based synthetic CT generation for MR‐only radiotherapy of prostate cancer patients with 0.35T MRI linear accelerator
Deep learning‐based synthetic CT generation for MR‐only radiotherapy of prostate cancer patients with 0.35T MRI linear accelerator
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Deep learning‐based synthetic CT generation for MR‐only radiotherapy of prostate cancer patients with 0.35T MRI linear accelerator
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Deep learning‐based synthetic CT generation for MR‐only radiotherapy of prostate cancer patients with 0.35T MRI linear accelerator
Deep learning‐based synthetic CT generation for MR‐only radiotherapy of prostate cancer patients with 0.35T MRI linear accelerator

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Deep learning‐based synthetic CT generation for MR‐only radiotherapy of prostate cancer patients with 0.35T MRI linear accelerator
Deep learning‐based synthetic CT generation for MR‐only radiotherapy of prostate cancer patients with 0.35T MRI linear accelerator
Journal Article

Deep learning‐based synthetic CT generation for MR‐only radiotherapy of prostate cancer patients with 0.35T MRI linear accelerator

2021
Request Book From Autostore and Choose the Collection Method
Overview
Purpose To develop a deep learning model to generate synthetic CT for MR‐only radiotherapy of prostate cancer patients treated with 0.35 T MRI linear accelerator. Materials and Methods A U‐NET convolutional neural network was developed to translate 0.35 T TRUFI MRI into electron density map using a novel cost function equalizing the contribution of various tissue types including fat, muscle, bone, and background air in training. The impact of training time, dataset size, image standardization, and data augmentation approaches was also quantified. Mean absolute error (MAE) between synthetic and planning CTs was calculated to measure the goodness of the model. Results With 20 patients in training, our U‐NET model has the potential to generate synthetic CT with a MAE of about 29.68 ± 4.41, 16.34 ± 2.67, 23.36 ± 2.85, and 105.90 ± 22.80 HU over the entire body, fat, muscle, and bone tissues, respectively. As expected, we found that the number of patients used for training and MAE are nonlinearly correlated. Data augmentation and our proposed loss function were effective to improve MAE by ~9% and ~18% in bony voxels, respectively. Increasing the training time and image standardization did not improve the accuracy of the model. Conclusion A U‐NET model has been developed and tested numerically to generate synthetic CT from 0.35T TRUFI MRI for MR‐only radiotherapy of prostate cancer patients. Dosimetric evaluation using a large and independent dataset warrants the validity of the proposed model and the actual number of patients needed for the safe usage of the model in routine clinical workflow.